Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 25, 2018

DrugPatentWatch Database Preview

Rifamycin Antibacterial Drug Class List

« Back to Dashboard

Drugs in Drug Class: Rifamycin Antibacterial

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sanofi Aventis Us	RIFADIN	rifampin	CAPSULE;ORAL	050420-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sanofi Aventis Us	RIFADIN	rifampin	INJECTABLE;INJECTION	050627-001	May 25, 1989	AP	RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sanofi Aventis Us	RIFAMATE	isoniazid; rifampin	CAPSULE;ORAL	061884-001	Approved Prior to Jan 1, 1982		RX	No	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Lupin Pharms	RIFAMPIN	rifampin	CAPSULE;ORAL	090034-001	Aug 21, 2013	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic

McKinsey

Deloitte

Argus Health

Merck

Chinese Patent Office

Teva

Fish and Richardson

Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.